← Back to Screener
Shoulder Innovations, Inc. (SI)
Price$14.90
Favorite Metrics
Price vs S&P 500 (26W)15.64%
Price vs S&P 500 (4W)-4.74%
Market Capitalization$307.65M
All Metrics
Book Value / Share (Quarterly)$6.82
P/TBV (Annual)2.09x
Revenue Growth (3Y)59.26%
Cash Flow / Share (Quarterly)$-1.75
Price vs S&P 500 (YTD)0.27%
Gross Margin (TTM)76.60%
Net Profit Margin (TTM)-9.86%
EPS (TTM)$-0.84
10-Day Avg Trading Volume0.07M
EPS Excl Extra (TTM)$-0.84
Revenue Growth (5Y)46.62%
EPS (Annual)$-1.41
ROI (Annual)-7.86%
Gross Margin (Annual)76.51%
Cash / Share (Quarterly)$6.03
Revenue Growth QoQ (YoY)-54.41%
ROA (Last FY)-7.20%
Revenue Growth TTM (YoY)151.02%
EBITD / Share (TTM)$-0.49
Operating Margin (TTM)-52.46%
Cash Flow / Share (Annual)$-1.75
P/B Ratio2.19x
P/B Ratio (Quarterly)2.09x
Net Income / Employee (Annual)$-0
ROA (TTM)-10.13%
EPS Incl Extra (Annual)$-1.41
Current Ratio (Annual)11.07x
Quick Ratio (Quarterly)9.44x
3-Month Avg Trading Volume0.08M
52-Week Price Return-98.93%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$6.82
P/S Ratio (Annual)6.50x
Asset Turnover (Annual)0.28x
52-Week High$17.94
EPS Excl Extra (Annual)$-1.41
Tangible BV CAGR (5Y)52.22%
26-Week Price Return22.53%
Quick Ratio (Annual)9.44x
13-Week Price Return7.19%
Total Debt / Equity (Annual)0.11x
Current Ratio (Quarterly)11.07x
Enterprise Value$295.688
Book Value / Share Growth (5Y)36.95%
Revenue / Employee (Annual)$1
Pretax Margin (Annual)-25.86%
Cash / Share (Annual)$6.03
3-Month Return Std Dev49.21%
Net Income / Employee (TTM)$-0
EBITDA Interim CAGR (5Y)53.41%
ROE (Last FY)-8.69%
EPS Basic Excl Extra (Annual)$-1.41
Total Debt / Equity (Quarterly)0.11x
EPS Incl Extra (TTM)$-0.84
ROI (TTM)-11.30%
P/S Ratio (TTM)8.65x
Revenue / Share (Annual)$5.46
Tangible BV / Share (Annual)$6.82
Free OCF CAGR (5Y)187.99%
EPS Growth TTM (YoY)-1135.45%
Year-to-Date Return4.20%
5-Day Price Return-0.73%
EPS Normalized (Annual)$-1.41
Net Profit Margin (Annual)-25.86%
Month-to-Date Return2.55%
Cash Flow / Share (TTM)$3.28
EBITD / Share (Annual)$-1.05
Operating Margin (Annual)-55.58%
LT Debt / Equity (Annual)0.11x
LT Debt / Equity (Quarterly)0.11x
EPS Basic Excl Extra (TTM)$-0.84
P/TBV (Quarterly)2.09x
P/B Ratio (Annual)2.09x
Pretax Margin (TTM)-9.86%
Book Value / Share (Annual)$6.82
Price vs S&P 500 (13W)4.81%
Beta15.72x
P/FCF (Annual)2.32x
Revenue / Share (TTM)$1.72
ROE (TTM)-13.16%
52-Week Low$10.92
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.31
4.31
4.31
4.33
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
SIShoulder Innovations, Inc. | 8.65x | 46.62% | 76.60% | -52.46% | $14.90 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
Shoulder Innovations is a commercial-stage medical device company specializing in shoulder arthroplasty solutions. Its product portfolio includes InSet Total and Reverse Shoulder Arthroplasty systems, along with ProVoyance surgical planning software and the InSet Tray System. The company targets the shoulder replacement market within orthopedic surgery.